Objective-The inflammatory response after myocardial infarction plays a crucial role in the healing process. Lately, there is accumulating evidence that the Wnt/Frizzled pathway may play a distinct role in inflammation. We have shown that secreted frizzled-related protein-1 (sFRP-1) overexpression reduced postinfarction scar size, and we noticed a decrease in neutrophil infiltration in the ischemic tissue. We aimed to further elucidate the role of sFRP-1 in the postischemic inflammatory process. Methods and Results-We found that in vitro, sFRP-1 was able to block leukocyte activation and cytokine production. We transplanted bone marrow cells (BMCs) from transgenic mice overexpressing sFRP-1 into wild-type recipient mice and compared myocardial healing with that of mice transplanted with wild-type BMCs. These results were compared with those obtained in transgenic mice overexpressing sFRP-1 specifically in endothelial cells or in cardiomyocytes to better understand the spatiotemporal mechanism of the sFRP-1 effect. Our findings indicate that when overexpressed in the BMCs, but not in endothelial cells or cardiomyocytes, sFRP-1 was able to reduce neutrophil infiltration after ischemia, by switching the balance of pro-and antiinflammatory cytokine expression, leading to a reduction in scar formation and better cardiac hemodynamic parameters. Conclusion-sFRP-1 impaired the loop of cytokine amplification and decreased neutrophil activation and recruitment into the scar, without altering the neutrophil properties. These data support the notion that sFRP-1 may be a novel antiinflammatory factor protecting the heart from damage after myocardial infarction. (Arterioscler Thromb Vasc Biol. 2011;31:e80-e87.)
L eukocyte recruitment is involved in the autoimmune reaction necessary for host defense against infection, and it is also required for wound healing. In the event of coronary artery occlusion and subsequent myocardial infarction (MI), the ischemic tissue endures an inflammatory reaction, which is a prerequisite for healing and scar formation. 1, 2 After cardiomyocyte death, the ischemic myocardium is characterized by a neutrophil infiltration, which facilitates the elimination of dead cells, followed by a myofibroblast proliferation improving tensile strength and an angiogenic response increasing tissue perfusion and cell survival. 3 Infarcted myocardial size is an important determinant of patient prognosis and depends, in part, on the complex healing processes. Modulation of the cellular and molecular mechanisms regulating the inflammatory response following MI could lead to a reduction of the deleterious scar evolution, which is the leading cause of heart failure and death. 4 There is accumulating evidence that the Wnt/Frizzled (Wnt/Fzd) pathway plays a distinct role in inflammation and immunity. 5, 6 It has been demonstrated that the Wnt/Fzd pathway plays a crucial role in a wide range of developmental processes, from stem cell maintenance to mammalian hematopoiesis and lymphopoiesis. [7] [8] [9] Studies on the role of WntD in Drosophila have elucidated a potential pivotal role of Wnt in the cascade of inflammation. 10 In humans, it has been shown that Wnt5A is secreted by activated antigen-presenting cells and by inflammatory synoviocytes from rheumatoid arthritis joints, through a Toll-like receptor dependent signaling via the central inflammatory regulator nuclear factor-B. 11, 12 Wnt5a in turn promotes cytokine synthesis. This finding has been recently been extended, demonstrating that Wnt5A targets its receptor Fzd5 through noncanonical signaling (increased phosphorylation of CamKII), and induces expression of the proinflammatory cytokines interleukin (IL)-1, IL-6, and IL-8. The Wnt5A signaling pathway was shown to be specifically blocked by secreted frizzled-related protein-1 (sFRP-1), a member of the sFRP family, which acts as a soluble modulator of the Wnt signaling. 13, 14 We have previously demonstrated an upregulation of sFRP-1 and distinct Wnt and Fzd member expression after MI. 15 In a transgenic mouse ubiquitously overexpressing sFRP-1, we used a model of MI induced by coronary artery ligation and found that sFRP-1 significantly reduces postinfarction scar size and improves cardiac hemodynamic parameters. Besides the impact of sFRP-1 on matrix remodeling and capillary growth, sFRP-1 decreased neutrophil infiltration in the ischemic tissue. 15 On the basis of our previous data and in light of recent reports on Wnt signaling and inflammation, we aimed to further elucidate the role of sFRP-1 in the postischemic inflammatory process. In the current report, we found that in vitro, sFRP-1 was able to block leukocyte activation and cytokine production. To extend these findings in vivo, we transplanted bone marrow cells (BMCs) from transgenic mice overexpressing sFRP-1 into wild-type recipient mice and compared myocardial healing with that of mice transplanted with wild-type BMCs, in a mouse model of MI. These results were compared with those obtained in transgenic mice overexpressing sFRP-1 specifically in endothelial cells (ECs) or in cardiomyocytes to better understand the spatiotemporal mechanism of the sFRP-1 effect. Our findings indicate that when overexpressed in the bone marrow (ie, leukocytes), but not in ECs or cardiomyocytes, sFRP-1 was able to reduce neutrophil infiltration after ischemia, by switching the balance of pro-and antiinflammatory cytokine expression, leading to a reduction in scar formation and better cardiac hemodynamic parameters.
Materials and Methods

In Vitro Assays
Cell Culture
HL-60 (a human myeloid leukemic cell line) and human umbilical vein endothelial cells were maintained in RPMI 1640 (Sigma Chemical Co) supplemented with 10% (v/v) heat-inactivated fetal bovine serum in a humidified atmosphere of 5% CO 2 at 37°C. For assays, confluent human umbilical vein ECs were switched for 24 hours from medium with serum to serum-free medium. 16 -18 
Neutrophil Isolation
Human neutrophils were isolated from whole blood obtained from normal human volunteers following a protocol described previously. 19 This technique allows for rapid isolation of functionally active neutrophils with Ͼ90% purity as demonstrated by flow cytometry analysis with CD 16 staining.
sFRP-1 Assays
Because the recombinant bovine FrzA protein used is almost identical to its homologous murine sFRP-1 protein (98% identity), in this report we refer to it as recombinant sFRP-1 protein (rsFRP-1). In all experiments, cells were activated with Ϸ10 nmol/L rsFRP-1 protein. 20 
Cytokine Expression and Polymerase Chain Reaction Analysis
Total RNA was prepared from HL-60 or human neutrophils in guanidinium thiocyanate buffer, and reverse transcription-polymerase chain reaction was performed as previously described.
Negative controls without reverse transcription were prepared in parallel for each RNA sample. Semiquantitative polymerase chain reaction for IL-1, IL-6, IL-8, IL-10, tumor necrosis factor-␣ (TNF-␣), monocyte chemotactic protein-1, and ␤-actin was performed as previously described. 21 All experiments were done in triplicate.
Inflammatory Cell Proliferation and Apoptosis
HL-60 and human neutrophils were incubated for 48 hours in the absence or presence of rsFRP-1. Cell proliferation was performed manually using a hemocytometer determining cell density. For apoptosis, inflammatory cells were incubated with TNF-␣ for 20 hours in the absence or presence of rsFRP-1. Cells were labeled with annexin V-fluorescein isothiocyanate (Dako) and CD 16-PC 5 fluorochrome (Immunotech). 22 The rate of apoptosis was determined by the ratio of apoptotic cells (CD 16Ϫ annexin Vϩ) to viable cells (CD 16ϩ annexin VϪ) by flow cytometry analysis (fluorescenceactivated cell sorting analyzer ODAM-ATC 3000). Each experiment was performed in triplicate.
Neutrophil Integrin Expression
HL-60 and human neutrophils were activated with TNF-␣ in the absence or presence of rsFRP-1. The cells were analyzed by flow cytometry for CD18, CD11a, and CD11b expression using fluorescein isothiocyanate-conjugated antibodies (BD Pharmingen). 23
Neutrophil F-Actin Polarization, Qualitative (Confocal Microscopy) and Quantitative (Flow Cytometry Assay)
For qualitative analysis, cell polarization was determined by F-actin staining with phalloidin-rhodamine (Molecular Probes). HL-60 and human neutrophil cells were plated on fibronectin-coated slides and stimulated with formyl-methionyl-leucyl-phenylalanine in the absence or presence of rsFRP-1. After fixation and incubation with phalloidin-rhodamine, fluorescence was examined with a confocal microscope (Nikon PCM 2000) as described. 24 For quantitative analysis, F-actin polymerization was evaluated by flow cytometry analysis using phalloidin-fluorescein isothiocyanate staining. 24 
BMC Transplantation
This study was conducted in accordance with both institutional and European Community guidelines for experimental animal use (L358 -86/609/EEC). To overexpress sFRP-1 specifically in leukocytes, we transplanted wild-type mice with bone marrow cells overexpressing sFRP-1. We have previously demonstrated that in this model, sFRP-1 transgene is expressed in bone marrow cells (BMCs) and circulatory mononuclear cells (line CMV/sFRP-1). 15 To further examine the engraftment of BMCs, we backcrossed the CMV/sFRP-1 or CMV/littermates (CMV/Litt) onto ROSA 26 mice (Jackson Laboratory) ubiquitously expressing ␤-galactosidase gene reporter, 25 generating ROSA-CMV/sFRP-1 mice or ROSA-CMV/ Litt (Ͼ6 generations), which were used as BMC donors. As analyzed by flow cytometry using 18-fluorodeoxyglucose staining, chimerism ranged from 45% to 85%, similar to results from previous hematopoietic studies using this model of BMC transplantation. 26 These mice are referred as BMC ROSA-CMV/sFRP-1 or BMC ROSA-CMV/Litt and were subjected to MI by ligation 2 months after irradiation as previously described. 26 
Transgenic Mouse Lines
Transgenic mice were previously constructed using the FrzA sequence (the bovine homolog of murine sFRP-1 gene). To simplify the text, we refer to FrzA as sFRP-1.
Two different transgenic mouse lines, previously described, were used in this study. In the first one, the sFRP-1 transgene was specifically overexpressed in ECs under a Tie-2 promoter (line Tie2-tTA/TRE-sFRP-1). 24 In the second one, the sFRP-1 transgene was specifically overexpressed in cardiomyocytes under ␣-myosin heavy chain (MHC) promoter (line ␣-MHC-tTA/TRE-sFRP-1). 21 Transgenic mice overexpressing sFRP-1 in ECs and their corresponding littermates are called Tie-2/sFRP-1 and Tie-2/Litt mice. Transgenic mice overexpressing sFRP-1 in cardiomyocytes and their corresponding littermates are called MHC/sFRP-1 and MHC/Litt mice.
In Vivo Models
The mouse model of MI, hemodynamic studies, necropsy examination, and data analysis were based on that previously described 15 (see supplemental material, available online at http://atvb.ahajournals.org).
Statistical Analysis
Results are expressed as meanϮSD. Comparisons of continuous variables between 2 groups were performed by a 1-way ANOVA and subsequently, if statistical significance was observed, by a 2-sided paired t test (Statview 5-1, Abacus). A value of PϽ0.05 was considered significant.
Results
Based on our previous data that mice overexpressing sFRP-1 have a decrease in neutrophil infiltration in ischemic tissue during the first week after MI, we aimed to study the impact of sFRP-1 on neutrophil properties in vitro, as well as the subsequent in vivo consequence of sFRP-1 overexpression in leukocytes, on the modulation of the inflammatory response after MI.
rsFRP-1 Does Not Impair Neutrophil Proliferation or Apoptosis
As shown in Figure 1A , HL-60 granulocyte cell line proliferation was not affected by rsFRP-1. rsFRP-1 did not induce apoptosis as demonstrated by annexin V staining in flow cytometry analysis ( Figure 1B , Pϭnot significant).
rsFRP-1 Did Not Modify Neutrophil Integrin Expression, Chemotactism, or Polarization
Leukocytes were either preincubated with sFRP-1 before addition of the activator, or rsFRP-1 and the activator were added together. We first analyzed by flow cytometry the expression of different transmembrane neutrophil integrins, using human neutrophils. TNF-␣ adjunction induced an increased expression of ␤ 2 -integrins (CD11a, CD11b, and CD18) on neutrophils. Preincubation of neutrophils with sFRP-1 did not modify TNF-␣induced ␤ 2 -integrin expression (data not shown). Likewise, preincubation or coactivation of rsFRP-1 with TNF-␣was not able to alter formyl-methionyl-leucyl-phenylalanine-induced neutrophil chemotactism.
Finally, we wondered whether rsFRP-1 could modify neutrophil polarization and consequently transendothelial migration. As analyzed by fluorescent time-lapse microscopy, using a gradient of formyl-methionyl-leucyl-phenylalanine, F-actin polarization was not affected by rsFRP-1 preincubation or adjunction ( Figure 1C ).
F-actin was also quantitatively analyzed by flow cytometry after formyl-methionyl-leucyl-phenylalanine stimulation of neutrophils, preincubated or not with rsFRP-1, and sFRP-1 did not modify the amount of F-actin (not shown).
In summary, rsFRP-1 did not modulate transmembrane integrin expression, neutrophil chemotactism, or polarization.
rsFRP-1 Impeded Neutrophil Activation
IL-1␤, TNF-␣, and IL-8 mRNA expressions were all significantly upregulated after TNF-␣ stimulation, in freshly iso- 
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Arterioscler Thromb Vasc Biol November 2011 lated human neutrophils. As demonstrated in Figure 1D , preincubation of human neutrophils with rsFRP-1 dramatically reduced TNF-␣-induced TNF-␣ and IL-8 mRNA upregulation (PϽ0.001). In contrast, rsFRP-1 did not modify TNF-␣ induced IL-1␤ expression.
In Vivo Overexpression of sFRP-1 in BMCs Reduced Neutrophil Infiltration in the Scar and Inversed the Balance of Pro-and Anti-Inflammatory Cytokine Expression
The in vivo effects of sFRP-1 on MI were studied on C57Bl6/J mice transplanted with sFRP-1 overexpressing BMCs (ROSA/sFRP-1 BMCs). As a control, BMCs from littermates were also transplanted in C57Bl6/J mice (ROSA/ Litt BMCs). Neutrophil infiltration, evaluated by myeloper-oxidase immunostaining, was dramatically decreased in the scar 2 and 7 days after infarction in ROSA/sFRP-1 BMC transplanted mice, compared with the ROSA/Litt BMC transplanted control mice (PϽ0.01) (Figure 2A) . No difference in macrophage and T lymphocyte infiltration was observed between ROSA/sFRP-1 BMC transplanted mice and ROSA/ Litt BMC transplanted control mice during the first 2 weeks. To assess whether leukocyte infiltration reduction was due to Note that the sFRP-1 transgene was not expressed in bone marrow mononuclear cells or in circulating white blood cells in Tie2/sFRP-1 transgenic mice ( Figure 3A) . No difference in neutrophil infiltration was observed in Tie2/sFRP-1 transgenic mice or in ␣-MHC/sFRP-1 transgenic mice, as compared with their respective littermates, 2 and 7 days after infarction. Endothelial or cardiomyocyte sFRP-1 overexpression did not alter macrophage or lymphocyte infiltration. It should be noted that leukocyte counts in the blood and bone marrow were similar 4 days after ligation in each group of mice (not shown).
We then investigated whether sFRP-1 overexpression in BMCs might affect cytokine production during the MI repair process. It is widely accepted that in this model, MI results in increased expression of inflammatory/antiinflammatory cytokine mRNA, such as TNF-␣, IL-1␤, monocyte chemotactic protein-1, IL-6, and IL-10, largely detected in the ischemic area 4 days after infarction. We observed that ROSA/sFRP-1 BMC transplantation led to a significant reduction of the proinflammatory cytokine IL-6 mRNA expression (day 4) and, by contrast, a significant increased expression of the antiinflammatory cytokine IL-10 mRNA (at day 7) compared with mRNA levels obtained in ROSA/Litt BMC transplanted mice (PϽ0.01) ( Figure 2B ). TNF-␣, IL-1␤, and monocyte chemotactic protein-1 expression was not impaired in ROSA/ sFRP-1 mice compared with their corresponding control littermates. Conversely, no difference in cytokine expression was observed between Tie-2/sFRP-1 or MHC/sFRP-1 mice and their corresponding control littermates ( Figure 2B ).
Overexpression of sFRP-1 in BMCs Increased Cell Density but Not Capillary Density in the Scar
The overall cell density and index of proliferation in the scar were increased in mice grafted with BMCs overexpressing sFRP-1 (ROSA/sFRP-1) and in mice overexpressing sFRP-1 in ECs (Tie-2/sFRP-1), compared with their corresponding control littermates 15 days after MI ( Figure 2C, PϽ0.01) . At 
Overexpression of sFRP-1 in BMCs Reduces Cardiac Rupture and Scar Size and Improves Hemodynamic Parameters
To evaluate the effect of sFRP-1 on postinfarction scar size, we compared myocardial evolution in 3 mouse lines overexpressing sFRP-1 (Tie-2, MHC, and BMC ROSA) to that in their corresponding littermates.
After MI, there was no difference in early mortality (within 24 hours after surgery) between the 3 groups. However, the incidence of fatal cardiac rupture of the left ventricular wall, confirmed by necropsy, was statistically significantly (PϽ0.01) lower in BMC ROSA /sFRP-1 mice (10.5%) compared with their corresponding control littermates (26.3%), as well as the other transgenic mouse lines and their corresponding control littermates (rangeϭ25% to 26.6%) ( Table 1) .
Fifteen days after MI, the percentage of left ventricular scar size was statistically significantly decreased in BMC ROSA/ sFRP-1 mice compared with that in all other groups (nՆ6 in each group, PϽ0.001; Figure 3A and 3B). Evolutions in scar and septal thickness are reported in Table 1 .
Changes in scar size and thickness in BMC ROSA/sFRP-1 mice were correlated with improved hemodynamic parameters as shown in Figure 4 and Table 2 . Differences in maximum and minimum dP/dt were amplified in BMC ROSA/sFRP-1 after dobutamine infusion compared with their corresponding control littermates (Figure 4 and Table 2 ). When overexpressed in ECs (Tie-2/sFRP-1), sFRP-1 improved hemodynamic parameters compared with their corresponding control littermates (Figure 4 ), but not when sFRP-1 was overexpressed in cardiomyocytes.
In summary, overexpression of sFRP-1 in BMCs reduced neutrophil infiltration, reduced scar size, and improved hemodynamic parameters, but it did not modify angiogenesis. In contrast, overexpression of sFRP-1 in ECs and cardiomyocytes did not reduce postinfarct scar size or leukocyte infiltration. When overexpressed in ECs (Tie-2/sFRP-1), Shown are early and late mortality after surgery. Early mortality was defined as death within 24 h of surgery, and cardiac rupture was defined as death 5 d after surgery. sFRP-1 indicates secreted frizzled-related protein-1; MHC, myosin heavy chain. *PϽ0.05 compared with littermates.
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sFRP-1 had an angiogenic effect, which correlated with an improvement of hemodynamic parameters. sFRP-1 overexpression in cardiomyocyte had no effect on hemodynamic parameters.
Discussion
Ischemic heart disease remains the leading cause of death in Western countries. Improving our knowledge and understanding of the healing process after MI could potentially lead to new therapeutic targets to avoid heart failure after MI. 4 To our knowledge, this is the first report of an in vivo study demonstrating that sFRP-1, a modulator of Wnt/Fzd pathway, can regulate the postischemic myocardial inflammatory process. We demonstrate that this regulation was effective in an autocrine manner, when sFRP-1 was expressed by leukocytes (ie, bone marrow cells), and that neutrophils were the specific Wnt/Fzd target in this model. These experiments provide evidence of how regulation of the inflammatory process by sFRP-1 could be beneficial for myocardial healing, through an impairment of the cytokine amplification loop. Because of the lethal effect of most Wnt/Fzd deletions, we used a novel approach to further elucidate the role of this pathway through a Wnt/Fzd modulator, sFRP-1. The sFRP proteins are able to bind either the Wnt ligands or the Fzd receptors (Fzd4, Fzd5, and Fzd7). 13, 24 In previous studies, we have shown that in vitro, sFRP-1 protects ECs from apoptosis and favors EC migration and differentiation, in a glycogen synthase kinase 3␤ and Rac1-dependent manner. In vitro, sFRP-1 expression has been previously demonstrated to lead to robust vessel formation in different angiogenic models (eg, tumoral, plug, chorioallantoic membrane assays). 16, 24 Similarly, in vivo, EC-specific overexpression of sFRP-1 in transgenic mice leads to increased muscle neovascularization in ischemiainduced angiogenesis. Because of these vascular properties, we investigated the role sFRP-1 in the healing process after MI. In a transgenic mouse ubiquitously overexpressing sFRP-1, it has been demonstrated that sFRP-1 plays an important role, increasing capillary density, reducing scar size, and improving hemodynamic parameters. 15 Studying this model, it was also noted that there was a significant reduction in leukocyte infiltration in the scar of sFRP-1 transgenic mice. Further characterization of these transgenic mice established that sFRP-1 was also overexpressed in the BMCs and circulating leukocytes. 15
sFRP-1 Effects In Vitro on Neutrophils
Since the first report of upregulated expression of cytokines such as interleukins IL-6, IL-8, and IL-15 by Wnt5a in rheumatoid arthritis synovial fibroblasts, there has been a surge of interest in Wnt signaling in the context of inflammation in pathogenic disorders. 11, 27, 28 It has been reported that Wnt5a-Fz5 signaling promotes IL-12 synthesis and enhances the inflammation induced by microbial stimulation in macrophages. 12 Recently, Pereira et al, using an in vitro model of inflammatory macrophage activation, reported that macrophages stimulated with interferon-␥ and lipopolysaccharide consistently upregulate Wnt5a via Toll-like receptor activation. Wnt5a in turn upregulates expression of the proinflammatory genes IL-6, IL-1␤, and IL-8. 13, 14 Wnt5A, by increasing phosphorylation of CamKII, is capable of activating the proinflammatory Ca2ϩ/CamKII pathways in macrophages. This effect was completely abrogated by sFRP-1 and inhibited the lipopolysaccharide/interferon-␥-induced Cam-KII phosphorylation. 13 Others reported that DKK1 (a Wnt blocker) was sufficient to block the overexpression of proinflammatory factors in retinal inflammation. 29 To verify that the Wnt/Fzd pathway alters the inflammatory process, we attempted to evaluate in vitro how sFRP-1 could modulate inflammatory cell activation. sFRP-1 affected leukocyte proliferation but did not play a role in leukocyte apoptosis, chemotactism, polarization, or integrin expression. However, sFRP-1 significantly impaired leukocyte activation in response to triggers. In response to TNF-␣, sFRP-1 significantly reduced in vitro TNF-␣ and IL-8 expression, which are cytokines known to contribute to the proinflammatory response. 30 -34 Our results corroborated the work of Pereira et al, 13, 14 demonstrating the potential effect of sFRP-1 in modulating the inflammatory response.
sFRP-1 Effects In Vivo
Previous reports on Wnt signaling in the context of inflammation studied in vitro mechanisms of leukocyte activation by Wnt and occasionally confirmed with ex vivo proof-ofconcept, in the context of pathogenic disorders. In the current report, we specifically studied myocardial healing using a mouse model of MI, to further elucidate the in vivo role of sFRP-1 and Wnt/Fzd in the inflammatory process.
The inflammatory response after MI is essential in the healing process. 1, 2 It contributes to the scar remodeling and ventricular shaping. Consequences of changes in the inflammatory response could be beneficial, leading to granulation tissue and restoring hemodynamic parameters, or harmful, leading to left ventricle dilatation and cardiac rupture. 1, 2, 35, 36 Neutrophils are activated in the bone marrow by cytokines (IL-6, IL-8, C5a, and TNF-␣) and secreted by ischemic tissue. After mobilization via the blood flow, they adhere on the endothelial layer and transmigrate into the infarct area. This is the earliest cell adhesion event following tissue insult. [37] [38] [39] [40] Activated neutrophils participate in the cleaning of the scar, but they can also in some cases be deleterious, increasing superoxide production, free radicals, and proinflammatory cytokines. 41 Using bone marrow transplantation, we overexpressed sFRP-1 specifically in leukocytes and compared its effect on the inflammatory processes, to that in overexpression in ECs or in cardiomyocytes. Specific sFRP-1 overexpression in BMCs altered the inflammatory response after MI. Neutrophil infiltration in the scar was significantly reduced within 48 hours after ischemia and lasted up to 7 days, but there was no reduction in macrophage or T lymphocyte infiltration. sFRP-1 significantly reduces IL-6 expression, a major cytokine in the proinflammatory response, and sFRP-1 favored IL-10, a potent antiinflam-matory cytokine. 30 -34 This effect was correlated with a specific reduction of post-MI cardiac rupture rate (with the caution that a limited number of mice were analyzed) and scar size and with an improvement in hemodynamic parameters.
Resolution of postinfarction inflammation is likely to involve multiple overlapping regulatory mechanisms controlling various proinflammatory pathways activated in the infarcted myocardium. In our study, in vivo, sFRP-1 not only increased IL-10 but also decreased IL-6 mRNA in a significant, early manner in mouse MI, and there was a trend toward a decrease in TNF-␣ and IL-1␤. In vitro, rsFRP-1 dramatically reduced TNF-␣ and IL-8 mRNA upregulation specifically in neutrophils. So there are multiple lines of evidence that sFRP-1's effect is mediated not only by IL-10 (or another unique cytokine) but also by an impairment of the balance of pro-and antiinflammatory cytokines. Moreover, the role of IL-10 in resolution of postinfarction inflammation remains controversial. 42, 43 As another example, Burchfield et al demonstrated that intramyocardial injection of bone marrow mononuclear cells mediates cardiac protection after MI and that this is, at least in part, dependent on IL-10. However, the IL-10-dependent improvement provided by transplanted cells was not caused by reduced infarct size, neutrophil infiltration, or capillary density. 44 With this approach, we also confirmed the angiogenic effect of sFRP-1 when overexpressed specifically in ECs and its impact on left ventricle function. However, sFRP-1 EC overexpression had no effect on leukocyte recruitment or cytokine expression. When overexpressed specifically in cardiomyocyte, sFRP-1 did not offer any advantage to myocardial healing. We speculate that this lack of effect may be due to the death of cardiomyocytes occurring during MI. The systematic use of corresponding littermates provided a reliable control for the sFRP-1 transgene effect.
Conclusions
In vivo modulation of the inflammatory response is difficult to monitor, and results of therapeutic alteration of the inflammatory response have often been controversial. Here, we demonstrated that sFRP-1, by switching the balance between proinflammatory and antiinflammatory cytokines, impaired the loop of amplification and decreased neutrophil activation and recruitment into the scar, without altering the neutrophil properties. These data support the notion that sFRP-1 may be a novel antiinflammatory factor protecting the heart from damage after MI.
